Management of Acute Demyelinating Attacks in the Pediatric Population: A Swiss Consensus Statement

Management of Acute Demyelinating Attacks in the Pediatric Population: A Swiss Consensus Statement

Background and methods: Acquired demyelinating syndromes (ADS) encompass distinct entities and occur in approximately 1/100,000 children. While the use of high dose intravenous corticosteroids is well-established, agreement on steroid taper and type of second line therapy is lacking. A comprehensive...

Full description

Bibliographic Details
Main Authors: Seline Hofer, Florian Bauder, Andrea Capone Mori, Andrew Chan, Patricia Dill, Stéphanie Garcia-Tarodo, Barbara Goeggel Simonetti, Annette Hackenberg, Judith Kalser, Oliver Maier, Regula Schmid, Susi Strozzi, Sandra Bigi, on behalf of the “Medico Scientific Advisory Board” of the Swiss Multiple Sclerosis Society
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Clinical and Translational Neuroscience
Subjects:
demyelination
pediatric multiple sclerosis
corticosteroid treatment
Online Access:https://www.mdpi.com/2514-183X/5/2/17

Internet

https://www.mdpi.com/2514-183X/5/2/17

Similar Items